117 related articles for article (PubMed ID: 1655110)
1. Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia.
Buchan AM; Xue D; Huang ZG; Smith KH; Lesiuk H
Neuroreport; 1991 Aug; 2(8):473-6. PubMed ID: 1655110
[TBL] [Abstract][Full Text] [Related]
2. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
Xue D; Huang ZG; Barnes K; Lesiuk HJ; Smith KE; Buchan AM
J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339
[TBL] [Abstract][Full Text] [Related]
3. L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat.
Morikawa E; Moskowitz MA; Huang Z; Yoshida T; Irikura K; Dalkara T
Stroke; 1994 Feb; 25(2):429-35. PubMed ID: 7508154
[TBL] [Abstract][Full Text] [Related]
4. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase.
Buchan AM; Gertler SZ; Huang ZG; Li H; Chaundy KE; Xue D
Neuroscience; 1994 Jul; 61(1):1-11. PubMed ID: 7526264
[TBL] [Abstract][Full Text] [Related]
5. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats.
Xue D; Slivka A; Buchan AM
Stroke; 1992 Jun; 23(6):894-9. PubMed ID: 1595111
[TBL] [Abstract][Full Text] [Related]
6. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
Nellgård B; Wieloch T
J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
[TBL] [Abstract][Full Text] [Related]
7. Transient forebrain ischemia protects against subsequent focal cerebral ischemia without changing cerebral perfusion.
Matsushima K; Hakim AM
Stroke; 1995 Jun; 26(6):1047-52. PubMed ID: 7762022
[TBL] [Abstract][Full Text] [Related]
8. AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.
Yao H; Ibayashi S; Nakane H; Cai H; Uchimura H; Fujishima M
Brain Res; 1997 Apr; 753(1):80-5. PubMed ID: 9125434
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats.
Buchan AM; Li H; Cho S; Pulsinelli WA
Neurosci Lett; 1991 Nov; 132(2):255-8. PubMed ID: 1664505
[TBL] [Abstract][Full Text] [Related]
10. Immediate or delayed mild hypothermia prevents focal cerebral infarction.
Xue D; Huang ZG; Smith KE; Buchan AM
Brain Res; 1992 Jul; 587(1):66-72. PubMed ID: 1525650
[TBL] [Abstract][Full Text] [Related]
11. Fructose-1,6-bisphosphate reduces infarct volume after reversible middle cerebral artery occlusion in rats.
Kuluz JW; Gregory GA; Han Y; Dietrich WD; Schleien CL
Stroke; 1993 Oct; 24(10):1576-83. PubMed ID: 8378964
[TBL] [Abstract][Full Text] [Related]
12. Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.
Doğan A; Rao AM; Başkaya MK; Rao VL; Rastl J; Donaldson D; Dempsey RJ
J Neurosurg; 1997 Dec; 87(6):921-6. PubMed ID: 9384405
[TBL] [Abstract][Full Text] [Related]
13. Secondary reduction in the apparent diffusion coefficient of water, increase in cerebral blood volume, and delayed neuronal death after middle cerebral artery occlusion and early reperfusion in the rat.
van Lookeren Campagne M; Thomas GR; Thibodeaux H; Palmer JT; Williams SP; Lowe DG; van Bruggen N
J Cereb Blood Flow Metab; 1999 Dec; 19(12):1354-64. PubMed ID: 10598940
[TBL] [Abstract][Full Text] [Related]
14. Effects of ketamine on outcome from temporary middle cerebral artery occlusion in the spontaneously hypertensive rat.
Ridenour TR; Warner DS; Todd MM; Baker MT
Brain Res; 1991 Nov; 565(1):116-22. PubMed ID: 1773349
[TBL] [Abstract][Full Text] [Related]
15. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
[TBL] [Abstract][Full Text] [Related]
16. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
Graham SH; Chen J; Lan JQ; Simon RP
J Pharmacol Exp Ther; 1996 Jan; 276(1):1-4. PubMed ID: 8558416
[TBL] [Abstract][Full Text] [Related]
17. AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
Buchan AM; Lesiuk H; Barnes KA; Li H; Huang ZG; Smith KE; Xue D
Stroke; 1993 Dec; 24(12 Suppl):I148-52. PubMed ID: 7504338
[TBL] [Abstract][Full Text] [Related]
18. A selective N-type Ca(2+)-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia.
Buchan AM; Gertler SZ; Li H; Xue D; Huang ZG; Chaundy KE; Barnes K; Lesiuk HJ
J Cereb Blood Flow Metab; 1994 Nov; 14(6):903-10. PubMed ID: 7929655
[TBL] [Abstract][Full Text] [Related]
19. Tizanidine is an effective agent in the prevention of focal cerebral ischemia in rats: an experimental study.
Berkman MZ; Zirh TA; Berkman K; Pamir MN
Surg Neurol; 1998 Sep; 50(3):264-70; discussion 270-1. PubMed ID: 9736090
[TBL] [Abstract][Full Text] [Related]
20. Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia.
Minger SL; Geddes JW; Holtz ML; Craddock SD; Whiteheart SW; Siman RG; Pettigrew LC
Brain Res; 1998 Nov; 810(1-2):181-99. PubMed ID: 9813316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
